NIH study advances personalised immunotherapy for metastatic breast cancer
In a clinical trial of 42 women with metastatic breast cancer, 28 (or 67 per cent) generated an immune reaction against their…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
National Cancer Institute
Vor Biopharma signs exclusive license pact with NCI for clinical-stage CD33 CAR-T
It is currently being evaluated in a multi-site Phase 1/2 clinical trial in children and young adults with relapsed or refractory…
Scientists double understanding of genetic risk of melanoma
Melanoma is a sometimes-deadly skin cancer, with an estimated 350,000 cases worldwide in 2015, resulting in nearly 60,000 deaths…
BioE Holdings inks license agreement with NCI for BK and JC Polyomavirus vaccines
The technology was developed in the laboratory of Dr Christopher B Buck at NCI, which is engaged in Polyomavirus research